BetterLife Announces Fully Subscribed Private Placement Financing
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 29 2024
0mins
Source: Newsfilter
Private Placement Announcement: BetterLife Pharma Inc. plans to raise $1,100,000 through a non-brokered private placement, offering units at $0.15 each, which include common shares and warrants for future purchases.
Focus on Therapeutics Development: The funds will be used to advance BETR-001, a non-hallucinogenic LSD derivative aimed at treating mental disorders, along with general working capital, while the company also develops another compound, BETR-002, for anxiety-related disorders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
